Schwegman, Lundberg & Woessner
121 S 8th St #1600 Minneapolis, Minnesota
View Lawyer's Website
About the Intellectual Property Law Firms
Meet the Intellectual Property Lawyers
Schwegman, Lundberg & Woessner - Chemicals and Pharmaceuticals
Biologics Price Competition and Innovation Act
Demonstrating BioSimilarity Under U.S. Law
Approvals of BioSimilars in Europe
Biologics vs Small Molecules
How to Navigate BioSimilar Challenges
FDA Guidelines for Demonstrating Biosimilarity
Litigation and BioSimilar Patenting
Naming Problems with BioSimilars
BioSimilar Patenting Litigation Involving Large Amounts of Money
Impact of US Hatch Waxman Act 1984
What is a BioSimilar?
Why Are Biologicals so Important?
Claim Maps and BioSimilars
Are BioSimilars Being Approved in the US?
What is a BioSimilar Product Under US Law?
Who Determines Substitution Factors?
Rewards of the Practice